Anastasia joined Forbion in 2019 as a Principal
Anastasia is responsible for deal origination, due diligence, valuation assessments and deal execution. Furthermore she will focus on implementing value strategies with portfolio companies post-investment. Previously, Anastasia was the Senior Equity Research Analyst at Kempen, one of the leading investment banks in Europe focused on life sciences. At Kempen, Anastasia’s research actively covered 25 European life sciences companies over the past 6 years. In addition she was involved in book-building and fundraising processes for various European biotech companies that jointly raised $ 4b through IPOs on Euronext, NASDAQ and through secondary/follow-on offerings. Finally, Anastasia directly advised many European and US cross-over and public investors on European biotech companies.